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The common causes for visual decrease in central retinal
vein occlusion are macular edema, macular ischemia and vit-
reous hemorrhage. Early treatment may be required to im-
prove vision in macular edema before irreversible
photoreceptor damage occurs. Retinal vein occlusion is asso-
ciated with varying amounts of retinal ischemia or macular
edema that results in the expression of vascular endothelial
growth factor (VEGF). Various reports and short-term studies
in the literature have shown that intravitreal bevacizumab and
ranibizumab are effective and safe in the treatment of macu-
lar edema secondary to retinal vein occlusion.1,2
We report a case of central retinal vein occlusion with mac-
ular edema that developed retino-choroidal ischemia follow-
ing intravitreal ranibizumab.Case report
A 41-year-old gentleman came with complaints of
decreased vision in the right eye since 2 weeks. He gave
history of undergoing Laser-Assisted in situ Keratomileusis(LASIK) in both eyes 6 years ago. He is a known diabetic since
5 years on conventional insulin therapy. On examination, his
visual acuity was 0.2+2 in the right eye and 1.03 in the left
eye. Anterior segment examination was unremarkable and
there was no afferent pupillary defect in both eyes. Intraocu-
lar pressure was 16 mmHg in both eyes. Dilated fundus
examination showed clear ocular media in both eyes and
the left eye was unremarkable. Right eye showed scattered
blot retinal hemorrhages, tortuous and congested venules
with cystoid macular edema. Disk showed cup disk ration
(CDR) 0.3 with healthy neuroretinal rim in both eyes. A diag-
nosis of central retinal vein occlusion with cystoid macular
edema in the right eye was made.
His lab test showed erythrocyte sedimentation rate (ESR)
08 mm/hr, HbA1c 10.6%, serum homocysteine 10.28 micro-
mol/L, slight increase in total cholesterol (5.57 micromol/L)
and low density lipoproteins (LDL) cholesterol (3.63
micromol/L). He was referred to the endocrinologist for man-
agement. Fundus fluorescein angiography (FFA) and optical
coherence tomography (OCT) were done. The right eye
FFA showed delayed venous filling with dilated and tortuous
venules. Late phase showed pooling of dye in petalloide:
al.com
mirates.
Figure 2. Color fundus photograph of the right eye showing scattered
retinal hemorrhage and an area of outer retinal opacification in the
macula involving the temporal horizontal raphe and inferior fovea.
326 N. Hussain, A. Hussainpattern around the fovea with late perivenous staining
(Fig. 1). The left eye showed normal study. OCT of the right
eye showed elevated foveal contour with extensive intrareti-
nal cystic changes and serous foveal detachment. The central
macular thickness was 592 microns and foveal thickness was
619 microns in the right eye. Based on this evaluation, he
was diagnosed to have non-ischemic central retinal vein
occlusion with cystoid macular edema in the right eye.
Three weeks after the control of diabetes, he underwent
intravitreal ranibizumab (0.5 mg) in the right eye. Post-injec-
tion period was uneventful. One month later, he came with
complaints of decreased vision in the right eye since 10 days.
His visual acuity was 0.1 in the right eye and 1.0 in the left
eye. Anterior segment examination was unremarkable in
both eyes. Intraocular pressure was 16 mmHg in the right
eye and 15 mmHg in the left eye. Dilated fundus examination
showed attached retina, scattered retinal hemorrhage and an
area of outer retinal opacification was seen in the macula
involving the fovea (Fig. 2). No gross macular thickening
was observed. An impression of resolved CRVO and acute
branch retinal artery occlusion or possible choroidal ischemia
was made in the right eye. He was advised FFA, OCT and
advised cardiological opinion. He underwent FFA, which
showed macular infarct with whole of temporal retina show-
ing lack of arteriolar and venular perfusion as well as choroi-
dal non-filling of dye suggestive of both outer retina-choroid
and inner retinal ischemia in the right eye. The retinal arteri-
oles appeared straightened and attenuated. The venular
filling was differential between the nasal and temporal side
of the retina across the optic disk (Fig. 3). Left eye angio-
graphic phases were all within normal limits. OCT showedFigure 1. Color photograph of the right eye showing scattered retinal hemorr
eye showed normal finding (Top right). FFA of the left eye showed normal
showed disk staining, perivenous staining, tortuous vessels and typical petalloi
right).widening of foveal contour and intraretinal edema was
evident. An impression of retino-choridal ischemia was made.
His cardiological evaluation was normal and he was put on
aspirin, lipitor and continued on antidiabetic treatment.
Three months later, his visual acuity was counting fingers
1.5 meters in the right eye. The fundus examination was same
as before.hages, tortuous vessels and cystoid macular edema (Top left) and the left
angiographic features (Bottom left) and late phase FFA of the right eye
d appearance of the macula suggestive of cystoid macular edema (Bottom
Figure 3. Early phase FA showing non-filling venules, straightening of arterioles and conspicuous absence of choroidal filling (Top left). Mid-phase FA
shows complete absence of inner retinal and choroidal filling in the temporal and superior quadrant and evident lamellar venous flow in the nasal
quadrant (Top left). FA images in the bottom (left/right) highlight the narrowing of arterioles, blunted end of vessels at the ischemic and non-ischemic
zone and complete absence of retino-choroidal angiographic characteristics in the ischemic area.
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Central retinal vein occlusion is one of the most common
retinal vascular diseases and often associated with moderate
to severe visual loss.3 It has been reported that monthly intra-
vitreal ranibizumab for macular edema from retinal vein
occlusion contributes to greater improvement in vision
related function compared to sham treated patients through
6 months.1,4 It has also found to be safe and effective with
significant impact on visual finction.5 No new safety events
were identified with long-term use of ranibizumab and rates
of serious adverse events potentially related to treatment
were consistent with prior ranibizumab trials.2 All available
data, suggest that intravitreal ranibizumab provided an effec-
tive treatment for macular edema secondary to central retinal
vein occlusion.1–5
Retino-choroidal infarction is an uncommon ophthalmic
complication in central retinal vein occlusion. The persistent
visual loss in our patient is caused by ischemic damage to
the retina and choroid. Reported cases of retinal choroidal
ischemia have been caused following intralesional steroid
injection,6,7 during the treatment of acute lymphoblastic
leukemia8 and in pregnancy induced hypertension and dessi-
minated intravascular coagulation.9
The risk factors for central retinal vein occlusion are sys-
temic hypertension, diabetes mellitus and open angle glau-
coma.9 In women, the risk of occlusion decreased with the
use of postmenopausal estrogens and increased with higher
erythrocyte sedimentation rates. Cardiovascular disease,
electrocardiographic abnormalities, history of treatment of
diabetes mellitus, higher blood glucose levels, lower albu-
min-globulin ratios, and higher alpha-globulin levels were
associated with increased risk only for ischemic CRVO.9 High-
er total plasma level of homocysteine was also found to be an
independent risk factor for central retinal vein occlusion (oddsratio 13)10 and thrombophilia.11 We do know that progressive
retinal vein occlusion can cause extensive ischemia of the ret-
ina, however, choroidal ischemia occurs as a result of defec-
tive retro-ocular circulation. This can only happen when
blood flow to the choroidal perfusion is affected.
Choroidal vascular compromise can acutely occur in
malignant hypertension and pre-eclampsia.12 Perfusion
abnormality depends primarily on the focal effect on chorio-
capillaries or effect on larger arterioles. Inflammatory condi-
tions like giant cell arteritis and Wegener’s granulomatosis
can also cause inflammatory occlusion of choriocapillaries or
occlusion of intra-orbital part of ophthalmic artery13 so does
vaso-occlusive diseases in a variety of diseases.14–16 This
condition results in varieties of choroidal infarction or choroi-
dal ischemia.
In the present case, the cause for retino-choroidal ische-
mia could not be determined. However, it is possible that
such an undesirable vascular event could have happened
due to occlusion of short posterior ciliary arteries with rea-
sons not known to us. The only risk factor was uncontrolled
blood sugar (HbA1c 10.6%) at the time of presentation.
This case demonstrates the fluorescein angiographic char-
acteristics of retino-choroidal ischemia occurring after the
treatment for central retinal vein occlusion and highlights that
such an event can occur in patients with central retinal vein
occlusion.Conflict of interest
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